Investorideas.com, a go-to investing platform, releases the second of a two-part series looking at news and developments ...

The gross proceeds to the Company from the exercise of the Existing Warrants together with the sale of the new warrants is expected to be approximately $6.2 million. The closing of the transaction is ...

Folks with "high-risk" bladder cancers -- tumors that had already invaded nearby muscle -- doubled the time they were ...

Keytruda, manufactured b... "Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud ...

Despite positive KEYNOTE-811 results, Merck & Co’s position in this setting is not devoid of threats from other competitors.

Merck & Co.’s best-selling drug Keytruda helped women with a hard-to-treat form of breast cancer live longer, according to ...

We recently compiled a list of the 10 Worst Cancer Stocks To Buy Now According to Short Sellers. In this article, we are ...

The head of NATO’s military committee says that Ukraine has the solid legal and military right to strike deep inside Russia ...

Keytruda shows promise as a first line option in cervical cancer cutting patients' mortality risk by a third in a Phase 3 ...

Authorities say a Massachusetts State Police recruit died a day after he became unresponsive and suffered a medical crisis during a defensive tactics training exercise. Twenty-five-year-old Enrique De ...

Ivonescimab demonstrated superior progression-free survival compared to Keytruda, positioning it as a potential leader ...